David P Foley, MD


  • Section of Liver and Kidney Surgery
  • Division of Transplantation
  • Program Director, Abdominal Transplant Surgery Fellowship

(608) 263-2527

600 Highland Ave.
MC 7375
Madison, WI 53792-3284


  • MD, Boston University, 1994
  • General Surgery Residency, University of Massachusetts Medical School, 1994-2001
  • Surgical Research Fellowship, University of Massachusetts Department of Surgery, 1996-1998
  • Transplant Surgical Fellow, University of Wisconsin Hospital and Clinics, Madison, WI, 2001-2003


Castle Connolly America’s Top Doctors Surgery

Madison Magazine Top Docs 2016 Award Surgery, Transplantation

Dr. Foley is involved with the following professional societies:

  • American Society of Transplant Surgeons
  • American Society of Transplantation
  • American Association for the Study of Liver Diseases
  • Association for Academic Surgery
  • Surgical Biology Club II
  • Society of University Surgeons
  • Central Surgical Association
  • Transplantation Society
  • Americas Hepato-Pancreato-Biliary Association
  • International Liver Transplant Society

Dr. Foley has been very active in leadership positions in national surgical and transplant societies. He has served as Co-Chair for the Grants Review Committee for the American Society of Transplant Surgeons. He served on the Executive Committee for the Association for Academic Surgery and Co-Chair of the Education Committee. He has been the Co-Chair and Chair of the Executive Committee for the Liver and Intestine Community of Practice for the American Society of Transplantation.

Clinical Specialties

Dr. Foley is certified by the American Board of Surgery in General Surgery. Dr. Foley’s clinical focus is in liver and kidney transplantation. Dr. Foley provides a wide range of services including kidney transplant, laparoscopic donor nephrectomy, liver resection, and liver transplant.

Research Interests

Dr. Foley’s clinical research interests include studying protective strategies to decrease organ damage and enhance organ function after kidney and liver transplantation. Dr. Foley focuses on identifying and modifying clinical risk factors that lead to poor liver function after liver transplantation. These include studying the use of older donor livers, livers recovered from donation after circulatory determination of death donors, and livers with steatosis. In addition, Dr. Foley leads clinical studies aimed at decreasing delayed kidney function after kidney transplantation.

Dr. Foley’s basic research efforts are focused on identifying novel protective strategies to minimize ischemia-reperfusion injury (IRI) in liver and kidney transplantation. More specifically, his laboratory investigates the cell-specific effects of augmenting endogenous antioxidant pathways in the setting of hepatic and renal IRI. Activation of these pathways in a cell-specific manner can decrease oxidative stress and may promote cellular recovery from these deleterious processes. The ultimate goal is to discover new pharmacologic therapies that can decrease IRI and improve organ function after kidney and liver transplantation.

Recent Publications

    • Personalizing the Kidney Transplant Decision: Who Doesn't Benefit From a Kidney Transplant?
    • Sawinski D, Foley DP
    • Clin J Am Soc Nephrol 2019 Oct 01;
    • [PubMed ID: 31575618]
    • A targeted fungal prophylaxis protocol with static dosed fluconazole significantly reduces invasive fungal infection after liver transplantation.
    • Jorgenson MR, Descourouez JL, Marka NA, Leverson GE, Smith JA, Andes DR, Fernandez LA, Foley DP
    • Transpl Infect Dis 2019 Oct; 21(5): e13156
    • [PubMed ID: 31390109]
    • Impact of Pre-Transplant Malignancy on Outcomes After Kidney Transplantation: United Network for Organ Sharing Database Analysis.
    • Livingston-Rosanoff D, Foley DP, Leverson G, Wilke LG
    • J. Am. Coll. Surg. 2019 Dec; 229(6): 568-579
    • [PubMed ID: 31666186]
    • Deficiencies in reproductive health counseling in liver transplant recipients.
    • Phillips PK, Saha S, Foley DP, Iruretagoyena JI, Said A
    • Clin Transplant 2019 Aug; 33(8): e13631
    • [PubMed ID: 31173406]
    • Safety of Antithymocyte Globulin in Patients Undergoing Liver Transplantation With Livers From Donation After Circulatory Death Donors.
    • Jorgenson MR, Descourouez JL, Felix DC, Hanlon BM, Leverson GE, Foley DP
    • Ann Pharmacother 2019 Oct; 53(10): 981-990
    • [PubMed ID: 31030529]

All Publications on PubMed